Playng defense against Lou Gehrig's disease.
Aebischer
Patrick
P
Swiss Federal Institute of Technology, Lausanne.
Kato
Ann C
AC
D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D000818:Animals; D001369:Axons / Q000473:pathology / Q000502:physiology; D001921:Brain; D016923:Cell Death; D015444:Exercise; D006801:Humans; D008297:Male; D009046:Motor Neurons / Q000473:pathology / Q000502:physiology; D009410:Nerve Degeneration; D009414:Nerve Growth Factors / Q000008:administration & dosage; D034622:RNA Interference; D000077185:Resveratrol; D013116:Spinal Cord; D033581:Stem Cell Transplantation; D013267:Stilbenes / Q000627:therapeutic use; D013482:Superoxide Dismutase / Q000235:genetics; D000072105:Superoxide Dismutase-1
D009414:Nerve Growth Factors; C000606290:SOD1 protein, human; D013267:Stilbenes; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1; D000077185:Resveratrol